Symbol="APTX"
AssetType="Common Stock"
Name="Aptinyx Inc"
Description="Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development and commercialization of new, patented and synthetic small molecules for the treatment of brain and nervous system disorders. The company is headquartered in Evanston, Illinois."
CIK="1674365"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1801 MAPLE AVENUE, SUITE 4300, EVANSTON, IL, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="4618200"
EBITDA="-53795000"
PERatio="None"
PEGRatio="None"
BookValue="0.27"
DividendPerShare="0"
DividendYield="0"
EPS="-0.98"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.436"
ReturnOnEquityTTM="-1.381"
RevenueTTM="0"
GrossProfitTTM="-54444000"
DilutedEPSTTM="-0.98"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.222"
AnalystTargetPrice="0.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="45.33"
PriceToBookRatio="0.327"
EVToRevenue="73.93"
EVToEBITDA="0.371"
Beta="1.367"
num_52WeekHigh="0.72"
num_52WeekLow="0.05"
num_50DayMovingAverage="0.0725"
num_200DayMovingAverage="0.202"
SharesOutstanding="67716000"
DividendDate="None"
ExDividendDate="None"
symbol="APTX"
open="0.07"
high="0.07"
low="0.07"
price="0.07"
volume="124367.00"
latest_trading_day="2023-08-30"
previous_close="0.07"
change="0.00"
change_percent="0.1468%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="97"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="3"
Volume_recent_avg="1112317"
Change_recent_avg="0.01"
Delta_recent_avg="0.01"
Variance_recent_avg="0.01"
Change_ratio_recent_avg="-0.37"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="3"
Aroon_momentum_negative="97"
image_negative_thumbnail_id_1="1096"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0129.jpeg"
image_negative_thumbnail_id_2="500"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0105.jpeg"
image_neutral_thumbnail_id_1="585"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0014.jpeg"
image_neutral_thumbnail_id_2="571"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0028.jpeg"
image_positive_thumbnail_id_1="703"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0005.jpeg"
image_positive_thumbnail_id_2="688"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0020.jpeg"
image_professor_thumbnail_id_1="1194"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
image_professor_thumbnail_id_2="1203"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
